Table of Contents
What is the rank of Cipla?
As of 17 September 2014, its market capitalisation was ₹49,611.58 crore (equivalent to ₹560 billion or US$7.5 billion in 2020), making it India’s 42nd largest publicly traded company by market value. On 23 April 2019, Cipla appointed Dr.
Who is the No 1 Medicine Company in India?
1. Sun Pharmaceutical Industries Ltd
Founder | Dilip Shanghvi |
---|---|
Headquarters | Goregaon, Mumbai |
Revenue | 30,091.4 crores INR (US$4.2 billion, 2019) |
Number of employees | 32,000 (2019) |
Subsidiaries | Ranbaxy Laboratories, Pharmalucence, Inc., etc |
Who is the leader of Cipla?
Umang Vohra (Sep 1, 2016–)
Cipla/CEO
Who is Cipla led?
Khwaja Abdul Hamied
Cipla/Founders
Why is Cipla the best Indian pharma company?
For decades, the Indian pharmaceutical industry has been driving better health outcomes for the economy. Cipla’s commitment to high quality standards has made us the most trusted brand among patients and one of the top Indian pharma companies among healthcare professionals.
How is Cipla’s domestic business?
In FY 19-20, Cipla’s overall domestic business contributed to 39% of the global revenues. Today, Cipla is the 3rd largest pharmaceutical company in India, with product portfolio spanning across various therapeutic areas including Respiratory, Anti-infectives, Cardio-metabolic, Gastro and Urology.
What is Cipla doing in Sri Lanka?
Cipla continues to be a Respiratory leader in Sri Lanka, Nepal, & Morocco. The Company continues to focus on deepening its presence in Australia through respiratory portfolio and in markets such as China, Brazil & Indonesia through in-house pipeline products and JV partnerships.
What is emerging markets region for Cipla?
Emerging Markets region for Cipla comprises of all markets outside of India, North America, South Africa/ Sub-Saharan Africa and Europe but includes North Africa and Australia. Cipla has presence in 52 countries in this region including direct to market models in 13 countries.
https://www.youtube.com/watch?v=U0O5RA4TYR4